Cargando…
Implementation of ultra-low-dose lung protocols in CT-guided lung biopsies: feasibility and safety in the clinical setting
OBJECTIVE: To evaluate the use of ultra-low-dose computed tomography (ULDCT) for CT-guided lung biopsy versus standard-dose CT (SDCT). METHODS: CT-guided lung biopsies from 115 patients (50 ULDCT, 65 SDCT) were analyzed retrospectively. SDCT settings were 120 kVp with automatic mAs modulation. ULDCT...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5805212/ https://www.ncbi.nlm.nih.gov/pubmed/28587537 http://dx.doi.org/10.1177/0300060517712165 |
_version_ | 1783298926899625984 |
---|---|
author | Frisch, Barbara K Slebocki, Karin Mammadov, Kamal Puesken, Michael Becker, Ingrid Maintz, David Chang, De-Hua |
author_facet | Frisch, Barbara K Slebocki, Karin Mammadov, Kamal Puesken, Michael Becker, Ingrid Maintz, David Chang, De-Hua |
author_sort | Frisch, Barbara K |
collection | PubMed |
description | OBJECTIVE: To evaluate the use of ultra-low-dose computed tomography (ULDCT) for CT-guided lung biopsy versus standard-dose CT (SDCT). METHODS: CT-guided lung biopsies from 115 patients (50 ULDCT, 65 SDCT) were analyzed retrospectively. SDCT settings were 120 kVp with automatic mAs modulation. ULDCT settings were 80 kVp with fixed exposure (20 mAs). Two radiologists evaluated image quality (i.e., needle artifacts, lesion contouring, vessel recognition, visibility of interlobar fissures). Complications and histological results were also evaluated. RESULTS: ULDCT was considered feasible for all lung interventions, showing the same diagnostic accuracy as SDCT. Its mean total radiation dose (dose–length product) was significantly reduced to 34 mGy-cm (SDCT 426 mGy-cm). Image quality and complication rates (P = 0.469) were consistent. CONCLUSIONS: ULDCT for CT-guided lung biopsies appears safe and accurate, with a significantly reduced radiation dose. We therefore recommend routine clinical use of ULDCT for the benefit of patients and interventionalists. |
format | Online Article Text |
id | pubmed-5805212 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | SAGE Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-58052122018-02-14 Implementation of ultra-low-dose lung protocols in CT-guided lung biopsies: feasibility and safety in the clinical setting Frisch, Barbara K Slebocki, Karin Mammadov, Kamal Puesken, Michael Becker, Ingrid Maintz, David Chang, De-Hua J Int Med Res Clinical Report OBJECTIVE: To evaluate the use of ultra-low-dose computed tomography (ULDCT) for CT-guided lung biopsy versus standard-dose CT (SDCT). METHODS: CT-guided lung biopsies from 115 patients (50 ULDCT, 65 SDCT) were analyzed retrospectively. SDCT settings were 120 kVp with automatic mAs modulation. ULDCT settings were 80 kVp with fixed exposure (20 mAs). Two radiologists evaluated image quality (i.e., needle artifacts, lesion contouring, vessel recognition, visibility of interlobar fissures). Complications and histological results were also evaluated. RESULTS: ULDCT was considered feasible for all lung interventions, showing the same diagnostic accuracy as SDCT. Its mean total radiation dose (dose–length product) was significantly reduced to 34 mGy-cm (SDCT 426 mGy-cm). Image quality and complication rates (P = 0.469) were consistent. CONCLUSIONS: ULDCT for CT-guided lung biopsies appears safe and accurate, with a significantly reduced radiation dose. We therefore recommend routine clinical use of ULDCT for the benefit of patients and interventionalists. SAGE Publications 2017-06-06 2017-12 /pmc/articles/PMC5805212/ /pubmed/28587537 http://dx.doi.org/10.1177/0300060517712165 Text en © The Author(s) 2017 http://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (http://www.creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage). |
spellingShingle | Clinical Report Frisch, Barbara K Slebocki, Karin Mammadov, Kamal Puesken, Michael Becker, Ingrid Maintz, David Chang, De-Hua Implementation of ultra-low-dose lung protocols in CT-guided lung biopsies: feasibility and safety in the clinical setting |
title | Implementation of ultra-low-dose lung protocols in CT-guided lung
biopsies: feasibility and safety in the clinical setting |
title_full | Implementation of ultra-low-dose lung protocols in CT-guided lung
biopsies: feasibility and safety in the clinical setting |
title_fullStr | Implementation of ultra-low-dose lung protocols in CT-guided lung
biopsies: feasibility and safety in the clinical setting |
title_full_unstemmed | Implementation of ultra-low-dose lung protocols in CT-guided lung
biopsies: feasibility and safety in the clinical setting |
title_short | Implementation of ultra-low-dose lung protocols in CT-guided lung
biopsies: feasibility and safety in the clinical setting |
title_sort | implementation of ultra-low-dose lung protocols in ct-guided lung
biopsies: feasibility and safety in the clinical setting |
topic | Clinical Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5805212/ https://www.ncbi.nlm.nih.gov/pubmed/28587537 http://dx.doi.org/10.1177/0300060517712165 |
work_keys_str_mv | AT frischbarbarak implementationofultralowdoselungprotocolsinctguidedlungbiopsiesfeasibilityandsafetyintheclinicalsetting AT slebockikarin implementationofultralowdoselungprotocolsinctguidedlungbiopsiesfeasibilityandsafetyintheclinicalsetting AT mammadovkamal implementationofultralowdoselungprotocolsinctguidedlungbiopsiesfeasibilityandsafetyintheclinicalsetting AT pueskenmichael implementationofultralowdoselungprotocolsinctguidedlungbiopsiesfeasibilityandsafetyintheclinicalsetting AT beckeringrid implementationofultralowdoselungprotocolsinctguidedlungbiopsiesfeasibilityandsafetyintheclinicalsetting AT maintzdavid implementationofultralowdoselungprotocolsinctguidedlungbiopsiesfeasibilityandsafetyintheclinicalsetting AT changdehua implementationofultralowdoselungprotocolsinctguidedlungbiopsiesfeasibilityandsafetyintheclinicalsetting |